FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000948610> ?p ?o ?g. }

• W2000948610 endingPage "1289" @default.
• W2000948610 startingPage "1280" @default.
• W2000948610 abstract "LIGHT (lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for herpesvirus entry mediator (HVEM), a receptor expressed by T lymphocytes) is a ligand for HVEM. LIGHT–HVEM interactions are important in T helper type 1 (Th1) immune responses. In some cases with early stages of cutaneous T cell lymphoma (CTCL), IL-2, IFN-γ, and Th1 chemokines are expressed in lesional skin, while IL-4, IL-5, and Th2 chemokines are dominant in advanced CTCL. In this study, we investigated roles of LIGHT and HVEM in the microenvironment of CTCL. LIGHT enhanced production of Th1 chemokines, such as CXC chemokine ligand (CXCL) 9, CXCL10, and CXCL11, from IFN-γ-treated dermal fibroblasts via phosphorylation of inhibitor κBα. Messenger RNA levels of these chemokines were increased in lesional skin of early CTCL. Interestingly, while LIGHT expression in CTCL skin correlated with disease progression, HVEM expression was significantly decreased in advanced CTCL skin. HVEM was detected in dermal fibroblasts in early CTCL skin, but not in advanced CTCL skin in situ. These results suggest that low HVEM expression on dermal fibroblasts in advanced CTCL skin attenuates expression of Th1 chemokines, which may contribute to a shift to a Th2-dominant microenvironment as disease progresses. LIGHT (lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for herpesvirus entry mediator (HVEM), a receptor expressed by T lymphocytes) is a ligand for HVEM. LIGHT–HVEM interactions are important in T helper type 1 (Th1) immune responses. In some cases with early stages of cutaneous T cell lymphoma (CTCL), IL-2, IFN-γ, and Th1 chemokines are expressed in lesional skin, while IL-4, IL-5, and Th2 chemokines are dominant in advanced CTCL. In this study, we investigated roles of LIGHT and HVEM in the microenvironment of CTCL. LIGHT enhanced production of Th1 chemokines, such as CXC chemokine ligand (CXCL) 9, CXCL10, and CXCL11, from IFN-γ-treated dermal fibroblasts via phosphorylation of inhibitor κBα. Messenger RNA levels of these chemokines were increased in lesional skin of early CTCL. Interestingly, while LIGHT expression in CTCL skin correlated with disease progression, HVEM expression was significantly decreased in advanced CTCL skin. HVEM was detected in dermal fibroblasts in early CTCL skin, but not in advanced CTCL skin in situ. These results suggest that low HVEM expression on dermal fibroblasts in advanced CTCL skin attenuates expression of Th1 chemokines, which may contribute to a shift to a Th2-dominant microenvironment as disease progresses. CC chemokine ligand CC chemokine receptor cutaneous T cell lymphoma CXC chemokine ligand CXC chemokine receptor herpesvirus entry mediator inhibitor κBα lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for HVEM, a receptor expressed by T lymphocytes lymphotoxin β receptor mycosis fungoides natural killer phosphorylated IκBα Sézary syndrome T helper type 1" @default.
• W2000948610 created "2016-06-24" @default.
• W2000948610 creator A5005347564 @default.
• W2000948610 creator A5007508591 @default.
• W2000948610 creator A5030954224 @default.
• W2000948610 creator A5037317056 @default.
• W2000948610 creator A5055921747 @default.
• W2000948610 creator A5067689004 @default.
• W2000948610 creator A5071072383 @default.
• W2000948610 creator A5074886107 @default.
• W2000948610 creator A5081771204 @default.
• W2000948610 creator A5091285871 @default.
• W2000948610 date "2012-04-01" @default.
• W2000948610 modified "2023-10-01" @default.
• W2000948610 title "Low Herpesvirus Entry Mediator (HVEM) Expression on Dermal Fibroblasts Contributes to a Th2-Dominant Microenvironment in Advanced Cutaneous T-Cell Lymphoma" @default.
• W2000948610 cites W1620571444 @default.
• W2000948610 cites W1643706151 @default.
• W2000948610 cites W1669027738 @default.
• W2000948610 cites W1691165945 @default.
• W2000948610 cites W1906768151 @default.
• W2000948610 cites W1947973480 @default.
• W2000948610 cites W1972725501 @default.
• W2000948610 cites W1972899220 @default.
• W2000948610 cites W1996098672 @default.
• W2000948610 cites W1996141167 @default.
• W2000948610 cites W2001651353 @default.
• W2000948610 cites W2004400781 @default.
• W2000948610 cites W2012515646 @default.
• W2000948610 cites W2018911810 @default.
• W2000948610 cites W2019307823 @default.
• W2000948610 cites W2023653272 @default.
• W2000948610 cites W2024665491 @default.
• W2000948610 cites W2029015547 @default.
• W2000948610 cites W2031254710 @default.
• W2000948610 cites W2034316821 @default.
• W2000948610 cites W2037351900 @default.
• W2000948610 cites W2048083871 @default.
• W2000948610 cites W2054384218 @default.
• W2000948610 cites W2054991963 @default.
• W2000948610 cites W2060795000 @default.
• W2000948610 cites W2068496857 @default.
• W2000948610 cites W2075404044 @default.
• W2000948610 cites W2076582266 @default.
• W2000948610 cites W2076653362 @default.
• W2000948610 cites W2078201723 @default.
• W2000948610 cites W2081511824 @default.
• W2000948610 cites W2082514292 @default.
• W2000948610 cites W2091620221 @default.
• W2000948610 cites W2096160655 @default.
• W2000948610 cites W2099397034 @default.
• W2000948610 cites W2109521866 @default.
• W2000948610 cites W2112494869 @default.
• W2000948610 cites W2113765407 @default.
• W2000948610 cites W2126643360 @default.
• W2000948610 cites W2129419143 @default.
• W2000948610 cites W2129902199 @default.
• W2000948610 cites W2130012132 @default.
• W2000948610 cites W2130196278 @default.
• W2000948610 cites W2135355605 @default.
• W2000948610 cites W2160501399 @default.
• W2000948610 cites W2164575383 @default.
• W2000948610 cites W2271253473 @default.
• W2000948610 doi "https://doi.org/10.1038/jid.2011.470" @default.
• W2000948610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22297640" @default.
• W2000948610 hasPublicationYear "2012" @default.
• W2000948610 type Work @default.
• W2000948610 sameAs 2000948610 @default.
• W2000948610 citedByCount "29" @default.
• W2000948610 countsByYear W20009486102013 @default.
• W2000948610 countsByYear W20009486102014 @default.
• W2000948610 countsByYear W20009486102015 @default.
• W2000948610 countsByYear W20009486102016 @default.
• W2000948610 countsByYear W20009486102017 @default.
• W2000948610 countsByYear W20009486102018 @default.
• W2000948610 countsByYear W20009486102019 @default.
• W2000948610 countsByYear W20009486102020 @default.
• W2000948610 countsByYear W20009486102021 @default.
• W2000948610 countsByYear W20009486102022 @default.
• W2000948610 countsByYear W20009486102023 @default.
• W2000948610 crossrefType "journal-article" @default.
• W2000948610 hasAuthorship W2000948610A5005347564 @default.
• W2000948610 hasAuthorship W2000948610A5007508591 @default.
• W2000948610 hasAuthorship W2000948610A5030954224 @default.
• W2000948610 hasAuthorship W2000948610A5037317056 @default.
• W2000948610 hasAuthorship W2000948610A5055921747 @default.
• W2000948610 hasAuthorship W2000948610A5067689004 @default.
• W2000948610 hasAuthorship W2000948610A5071072383 @default.
• W2000948610 hasAuthorship W2000948610A5074886107 @default.
• W2000948610 hasAuthorship W2000948610A5081771204 @default.
• W2000948610 hasAuthorship W2000948610A5091285871 @default.
• W2000948610 hasBestOaLocation W20009486101 @default.
• W2000948610 hasConcept C12823836 @default.
• W2000948610 hasConcept C13373296 @default.
• W2000948610 hasConcept C13425408 @default.
• W2000948610 hasConcept C203014093 @default.
• W2000948610 hasConcept C2522874641 @default.
• W2000948610 hasConcept C2776780870 @default.
• W2000948610 hasConcept C2777756187 @default.

• next